BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15159023)

  • 1. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
    Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
    Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
    Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
    Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variants of DLC1 in colorectal and ovarian tumours.
    Wilson PJ; McGlinn E; Marsh A; Evans T; Arnold J; Wright K; Biden K; Young J; Wainwright B; Wicking C; Chenevix-Trench G
    Hum Mutat; 2000; 15(2):156-65. PubMed ID: 10649492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
    Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
    Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of deletion in the chromosomal 8p21.3-23 region with the development of invasive head & neck squamous cell carcinoma in Indian patients.
    Bhattacharya N; Tripathi A; Dasgupta S; Sabbir MG; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
    Indian J Med Res; 2003 Aug; 118():77-85. PubMed ID: 14680203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.
    Cetin E; Cengiz B; Gunduz E; Gunduz M; Nagatsuka H; Bekir-Beder L; Fukushima K; Pehlivan D; N MO; Nishizaki K; Shimizu K; Nagai N
    Neoplasma; 2008; 55(4):299-304. PubMed ID: 18505340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
    Mao L; Fan YH; Lotan R; Hong WK
    Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
    Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
    Kim SK; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman WN; Hong WK; Lotan R; Mao L
    Cancer Res; 1996 Jun; 56(11):2519-21. PubMed ID: 8653689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
    van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D
    Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
    Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.